Population Health

<p>Naomi Fried, PharmStars' founder and CEO, discusses the company's spring 2023 cohort, and its call for applications to digital health groups across the world who focus on women's health and health equity for underserved populations.</p>

The RSV, flu and COVID-19 tripledemic is leading to lengthy waits in ERs across the country.

<p>James Hury, deputy director and chief innovation officer at the Translational Research Institute for Space Health, explains what excites him about the future of space flight.</p> <p> </p>

<p>The Translational Research Institute for Space Health's deputy director and chief innovation officer, James Hury, talks about the ways healthcare innovators work with space exploration companies to study astronaut health in order to enhance healthcare on Earth.</p> <p> </p>

<p>The senior data scientist for the Singapore Ministry of Health's Office of Healthcare Transformation, Praveen Deorani, believes that an understanding of people's health engagement is central to getting them to manage their own health.</p>

<p>Abigail Katz and Leslie Iburg with United Language Group talk about the challenges that come with eventual expiration of the federal public health emergency and what is needed to reach beneficiaries.</p>

Last week ASPR extended flexibility to states to use Tamiflu in state stockpiles that were previously reserved for a pandemic flu.

When people have negative experiences finding care or are matched with the wrong provider, they're more likely to opt out of the healthcare system.

The issue is one of demand, not supply, experts say.

Overall, 51% of enrolled patients using Adstiladrin therapy achieved a complete response, with all signs of cancer disappearing.